Academic
Publications
Kawasaki Disease in a Pediatric Intensive Care Unit: A Case-Control Study

Kawasaki Disease in a Pediatric Intensive Care Unit: A Case-Control Study,10.1542/peds.2008-1275,Pediatrics,S. R. Dominguez,K. Friedman,R. Seewald,M.

Kawasaki Disease in a Pediatric Intensive Care Unit: A Case-Control Study   (Citations: 9)
BibTex | RIS | RefWorks Download
Journal: Pediatrics , vol. 122, no. 4, pp. e786-e790, 2008
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...Recently, two case-controlled studies described patients with KD admitted to the PICU with hypotensive shock [2, 3]. Our patient and the series reported by Dominguez et al. [2] were fulfilling the criteria of KD shock syndrome (KDSS) established by Kanegaye et al. [3]...
    • ...Recently, two case-controlled studies described patients with KD admitted to the PICU with hypotensive shock [2, 3]. Our patient and the series reported by Dominguez et al. [2] were fulfilling the criteria of KD shock syndrome (KDSS) established by Kanegaye et al. [3]...

    Farah Thabetet al. Shock: an unusual presentation of Kawasaki disease

    • ...Those previously reported with KDSS, as here, were older than the median 1- to 2-year age for KD. KDSS patients have earlier onset of more severe CA abnormalities, have poor response to IVIG, and often require aggressive therapy with subsequent doses of IVIG, steroids, and/or infliximab [4, 6]. Thrombocytopenia and coagulation abnormalities, which are rarely seen in KD, appear common in KDSS [4, 6]...
    • ...Those previously reported with KDSS, as here, were older than the median 1- to 2-year age for KD. KDSS patients have earlier onset of more severe CA abnormalities, have poor response to IVIG, and often require aggressive therapy with subsequent doses of IVIG, steroids, and/or infliximab [4, 6]. Thrombocytopenia and coagulation abnormalities, which are rarely seen in KD, appear common in KDSS [4, 6]...

    Deane Yimet al. Coronary Artery Dilatation in Toxic Shock-Like Syndrome: The Kawasaki ...

    • ...Although the precise pathogenesis underlying the development of KDSS remains unclear, possible explanations include vasculitis with ongoing capillary leak, myocardial dysfunction, and cytokine dysregulation [2]...

    Toru Watanabe. Shock following administration of contrast medium in a patient with Ka...

    • ...The risk factors for nonresponse to treatment include male gender, treatment before the fifth day of illness, admission to the intensive care unit, low platelet count (10 9 103/ll), and elevated ALT (C80 U/l) or CRP (C8 mg/dl) [5, 7, 15, 22, 29]...

    Laura L. Blaisdellet al. Infliximab Treatment for Pediatric Refractory Kawasaki Disease

Sort by: